Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) - An ACCRU Network study

T. Bekaii-Saab, F. Ou, D. Anderson, D. Ahn, P. Boland, K. Ciombor, N. Jacobs, R. Desnoyers, J. Cleary, J. Meyers, E. Chiorean, K. Pedersen, A. Barzi, J. Sloan, J. McCune, M. Lacouture, H. Lenz, A. Grothey

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)v105
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this